ClinicalTrials.gov
public full text
Public Domain
Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic Syndrome
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)#148728
- Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients#172532
- Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics#314308
- Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness#184761
- Metformin for Weight Loss in Schizophrenia#172525
Record · ID 474898
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive